| Utestående aktier | 41,924,941 shares |
| Insideraktier | 4 546 894 shares |
| Insynsägande | 10,85 % |
| Totalt antal insynspersoner | 37 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
5081 out of 11219Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
SCYNEXIS, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Alta Biopharma Management Ii Llc
10% Owner -
|
45 736 | 4 574 | |
|
Alta Biopharma Partners Ii Lp
10% Owner -
|
45 736 | 4 574 | |
|
Alta Embarcadero Biopharma Partners Ii Llc
10% Owner -
|
45 736 | 4 574 | |
| Armando Anido Director - [D] | 71 000 | 71 000 | |
| Gonzalez David Angulo Chief Executive Officer, Director - [D] [O] | 816 598 | 816 598 | |
| Laurent Arthaud Director - [D] | 3 738 | 374 | |
|
Farah Champsi
10% Owner -
|
45 736 | 4 574 | |
| Mounia Chaoui | 3 480 | ||
| Christine Coyne Chief Commercial Officer - [O] | 58 200 | 58 200 | |
|
Joseph Edelman
10% Owner -
|
2 400 000 | 1 800 000 | |
|
F.C.P.R. Genavent
10% Owner -
|
237 598 | 23 760 | |
|
FCPR Biotechnology Fund
10% Owner -
|
295 077 | 29 508 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Eric Francois Chief Financial Officer - [O] | 11 732 | 11 732 | |
| Steven C Gilman Director - [D] | 70 000 | 70 000 | |
| Michael C Garrett Vice President - [O] | 6 216 | 622 | |
| Ann Hanham Director - [D] | 69 622 | 69 622 | |
| David C Hastings Director - [D] | 69 183 | 69 183 | |
| Pamela J Kirby Director - [D] | 25 590 | 2 559 | |
| Patrick Langlois Director - [D] | 10 503 | 1 050 | |
| Guy Macdonald Director - [D] | 78 000 | 78 000 | |
| Patrick Machado Director - [D] | 60 000 | 6 000 | |
| ivor Macleod Chief Financial Officer - [O] | 260 696 | 260 696 | |
| Marion McCourt | 9 217 | ||
| Jean-Yves Nothias Director - [D] | 295 077 | 29 508 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Osborne, Jr. Charles F Chief Financial Officer - [O] | 17 900 | 1 790 | |
| Edward Penhoet | 8 800 | ||
|
Perceptive Advisors Llc
10% Owner -
|
1 800 000 | 1 800 000 | |
|
Perceptive Life Sciences Master Fund Ltd
10% Owner -
|
1 800 000 | 1 800 000 | |
| Eileen Pruette | 25 230 | ||
| Yves J Ribeill President and CEO, Director - [D] [O] | 1 190 | 119 | |
| Carole Sable | 26 970 | ||
|
Sanofi
10% Owner -
|
3 177 057 | 317 706 | |
| Scott Sukenick Chief Legal Officer - [O] | 436 706 | 436 706 | |
| Marco Taglietti Chief Executive Officer, Director - [D] [O] | 272 068 | 272 068 | |
| Brian Philippe Tinmouth Director - [D] | 74 000 | 74 000 | |
|
Capital II Ventech
10% Owner -
|
414 211 | 41 421 | |
| Jonathan Sears Woodall Interim Chief FinancialOfficer - [O] | 1 000 | 100 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SCYX / SCYNEXIS, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SCYX / SCYNEXIS, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 2025-06-26 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 23 000 | 74 000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | Macdonald Guy | SCYX | Common Stock | D | 23 000 | 78 000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 23 000 | 69 183 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | HANHAM ANN | SCYX | Common Stock | D | 23 000 | 69 622 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | GILMAN STEVEN C | SCYX | Common stock | D | 23 000 | 70 000 | ||||||
| 2025-06-30 | 2025-06-26 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 23 000 | 71 000 | ||||||
| 2025-04-10 | 2025-04-09 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 0,8400 | 23 000 | 19 | 816 598 | ||||
| 2025-03-20 | 2025-03-20 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,0500 | 13 800 | 14 | 793 598 | ||||
| 2025-03-20 | 2025-03-19 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,0700 | 5 000 | 5 | 779 798 | ||||
| 2025-01-27 | 2025-01-23 | 4 | Sukenick Scott | SCYX | Common Stock | D | 92 511 | 436 706 | ||||||
| 2025-01-27 | 2025-01-23 | 4 | Macleod ivor | SCYX | Common Stock | D | 92 511 | 260 696 | ||||||
| 2025-01-27 | 2025-01-23 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 262 927 | 770 798 | ||||||
| 2024-09-16 | 2024-09-12 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,3700 | 20 000 | 27 | 507 871 | ||||
| 2024-06-21 | 2024-06-20 | 4 | Macdonald Guy | SCYX | Common Stock | D | 23 000 | 55 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 23 000 | 46 183 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 23 000 | 47 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 23 000 | 51 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 23 000 | 48 000 | ||||||
| 2024-06-21 | 2024-06-20 | 4 | HANHAM ANN | SCYX | Common Stock | D | 23 000 | 46 622 | ||||||
| 2024-02-16 | 2024-02-16 | 4 | Sukenick Scott | SCYX | Common Stock | D | 1,6300 | −15 179 | −25 | 336 195 | ||||
| 2024-01-30 | 2024-01-26 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 290 590 | 479 871 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | Macleod ivor | SCYX | Common Stock | D | 143 675 | 160 185 | ||||||
| 2024-01-30 | 2024-01-26 | 4 | Sukenick Scott | SCYX | Common Stock | D | 143 675 | 351 374 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 10 000 | 23 183 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | HANHAM ANN | SCYX | Common Stock | D | 10 000 | 23 622 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 10 000 | 24 000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 10 000 | 25 000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 10 000 | 28 000 | ||||||
| 2023-06-23 | 2023-06-15 | 4 | Macdonald Guy | SCYX | Common Stock | D | 10 000 | 32 000 | ||||||
| 2023-05-17 | 2023-05-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 50 000 | 203 599 | ||||||
| 2023-01-31 | 2023-01-27 | 4 | Sukenick Scott | SCYX | Common Stock | D | 100 000 | 153 599 | ||||||
| 2023-01-03 | 2023-01-01 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 110 000 | 185 181 | ||||||
| 2022-10-26 | 2022-10-24 | 4 | Macleod ivor | SCYX | Common Stock | D | 15 000 | 15 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 10 000 | 18 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | Macdonald Guy | SCYX | Common Stock | D | 10 000 | 22 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 10 000 | 13 183 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | HANHAM ANN | SCYX | Common Stock | D | 10 000 | 13 622 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 10 000 | 14 000 | ||||||
| 2022-06-22 | 2022-06-17 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 10 000 | 15 000 | ||||||
| 2022-04-28 | 2022-04-26 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 3,45 | 75 000 | 75 000 | |||||
| 2022-04-28 | 2022-04-26 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,0000 | 75 000 | 225 | 272 068 | ||||
| 2022-04-28 | 2022-04-26 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 3,45 | 3 500 | 3 500 | |||||
| 2022-04-28 | 2022-04-26 | 4 | Sukenick Scott | SCYX | Common Stock | D | 3,0000 | 3 500 | 10 | 53 499 | ||||
| 2022-02-08 | 2022-02-04 | 4 | Coyne Christine | SCYX | Stock Option (Right to Buy) | D | 4,60 | 75 000 | 75 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Coyne Christine | SCYX | Common Stock | D | 43 200 | 58 200 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 4,60 | 70 000 | 70 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Sukenick Scott | SCYX | Common Stock | D | 40 700 | 49 899 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 4,60 | 85 000 | 85 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 51 100 | 74 981 | ||||||
| 2022-02-08 | 2022-02-04 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 4,60 | 232 000 | 232 000 | |||||
| 2022-02-08 | 2022-02-04 | 4 | Taglietti Marco | SCYX | Common Stock | D | 87 200 | 196 968 | ||||||
| 2021-06-21 | 2021-06-16 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-06-21 | 2021-06-16 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 7,51 | 10 000 | 10 000 | |||||
| 2021-05-12 | 2021-05-10 | 4 | Coyne Christine | SCYX | Stock Option (Right to Buy) | D | 6,50 | 125 000 | 125 000 | |||||
| 2021-05-12 | 2021-05-10 | 4 | Coyne Christine | SCYX | Common Stock | D | 15 000 | 15 000 | ||||||
| 2021-03-31 | 2020-07-06 | 4/A | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-03-31 | 2020-07-06 | 4/A | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 0,73 | 55 000 | 55 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 7,47 | 170 000 | 170 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 7,47 | 40 000 | 40 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 7,47 | 65 000 | 65 000 | |||||
| 2021-02-02 | 2021-01-29 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 7,47 | 65 000 | 65 000 | |||||
| 2021-01-26 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 8,9500 | −33 849 | −303 | 1 800 000 | ||||
| 2021-01-26 | 2021-01-22 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 8,1600 | −285 151 | −2 327 | 1 833 849 | ||||
| 2021-01-26 | 2021-01-21 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 7,3800 | −95 000 | −701 | 2 120 000 | ||||
| 2021-01-26 | 2021-01-20 | 4 | PERCEPTIVE ADVISORS LLC | SCYX | Common Stock | I | 7,4300 | −185 000 | −1 375 | 2 215 000 | ||||
| 2021-01-26 | 3 | EDELMAN JOSEPH | SCYX | Common Stock | I | 2 400 000 | ||||||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock Warrant | D | 7,33 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock Warrant | D | 8,25 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Tinmouth Brian Philippe | SCYX | Common Stock | D | 6,2500 | 8 000 | 50 | 8 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 8,25 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock Warrant | D | 7,33 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Sukenick Scott | SCYX | Common Stock | D | 6,2500 | 1 600 | 10 | 9 099 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 8,25 | 20 000 | 20 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock Warrant | D | 7,33 | 20 000 | 20 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,2500 | 40 000 | 250 | 109 668 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock Warrant | D | 7,33 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock Warrant | D | 8,25 | 4 000 | 4 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Macdonald Guy | SCYX | Common Stock | D | 6,2500 | 8 000 | 50 | 12 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock Warrant | D | 8,25 | 1 600 | 1 600 | |||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock Warrant | D | 7,33 | 1 600 | 1 600 | |||||
| 2020-12-23 | 2020-12-21 | 4 | HANHAM ANN | SCYX | Common Stock | D | 6,2500 | 3 200 | 20 | 3 622 | ||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock Warrant | D | 7,33 | 2 000 | 2 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock Warrant | D | 8,25 | 2 000 | 2 000 | |||||
| 2020-12-23 | 2020-12-21 | 4 | GILMAN STEVEN C | SCYX | Common Stock | D | 6,2500 | 4 000 | 25 | 4 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock Warrant | D | 7,33 | 300 | 300 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock Warrant | D | 8,25 | 300 | 300 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Francois Eric | SCYX | Common Stock | D | 6,2500 | 600 | 4 | 11 732 | ||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock Warrant | D | 7,33 | 2 500 | 2 500 | |||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock Warrant | D | 8,25 | 2 500 | 2 500 | |||||
| 2020-12-23 | 2020-12-21 | 4 | ANIDO ARMANDO | SCYX | Common Stock | D | 6,2500 | 5 000 | 31 | 5 000 | ||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant | D | 8,25 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant | D | 7,33 | 800 | 800 | |||||
| 2020-12-23 | 2020-12-21 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 6,2500 | 1 600 | 10 | 23 780 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 6,8100 | −4 323 | −29 | 22 180 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 9,8000 | −1 175 | −12 | 26 303 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Francois Eric | SCYX | Common Stock | D | 6,8100 | −3 480 | −24 | 11 132 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Francois Eric | SCYX | Common Stock | D | 9,8000 | −979 | −10 | 14 412 | ||||
| 2020-12-04 | 2020-11-25 | 4 | Sukenick Scott | SCYX | Common Stock | D | 6,8100 | −2 613 | −18 | 7 499 | ||||
| 2020-12-04 | 2020-02-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 9,8000 | −783 | −8 | 9 912 | ||||
| 2020-07-08 | 2020-07-06 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-07-08 | 2020-07-06 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 0,73 | 45 000 | 45 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 0,86 | 900 000 | 900 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 0,86 | 450 000 | 450 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 0,86 | 375 000 | 375 000 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 0,86 | 250 000 | 250 000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | Tinmouth Brian Philippe | SCYX | Stock Option (right to buy) | D | 0,73 | 70 000 | 70 000 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 1,10 | 166 667 | 166 667 | |||||
| 2019-12-16 | 2019-12-12 | 4 | Taglietti Marco | SCYX | Common Stock | D | 0,9000 | 166 667 | 150 | 693 682 | ||||
| 2019-08-22 | 2019-08-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,1100 | 9 500 | 11 | 526 015 | ||||
| 2019-08-22 | 2019-08-20 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,1100 | 500 | 1 | 516 515 | ||||
| 2019-08-19 | 2019-08-15 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,0100 | 10 015 | 10 | 516 015 | ||||
| 2019-06-20 | 2019-06-18 | 4 | HANHAM ANN | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | HASTINGS DAVID C | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | Macdonald Guy | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | ANIDO ARMANDO | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-06-20 | 2019-06-18 | 4 | GILMAN STEVEN C | SCYX | Stock Option (Right to Buy) | D | 1,29 | 45 000 | 45 000 | |||||
| 2019-04-18 | 2019-04-17 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6300 | 25 000 | 41 | 506 000 | ||||
| 2019-02-19 | 2019-02-15 | 4 | Angulo Gonzalez David | SCYX | Stock Option (Right to Buy) | D | 1,38 | 150 000 | 150 000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 150 000 | 271 790 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Francois Eric | SCYX | Stock Option (Right to Buy) | D | 1,38 | 125 000 | 125 000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Francois Eric | SCYX | Common Stock | D | 125 000 | 149 917 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Sukenick Scott | SCYX | Stock Option (Right to Buy) | D | 1,38 | 100 000 | 100 000 | |||||
| 2019-02-19 | 2019-02-15 | 4 | Sukenick Scott | SCYX | Common Stock | D | 100 000 | 102 959 | ||||||
| 2019-02-19 | 2019-02-15 | 4 | Taglietti Marco | SCYX | Stock Option (Right to Buy) | D | 1,38 | 700 000 | 700 000 | |||||
| 2019-01-23 | 2019-01-21 | 4 | ANIDO ARMANDO | SCYX | Stock Option (right to buy) | D | 0,74 | 70 000 | 70 000 | |||||
| 2019-01-14 | 2019-01-10 | 4 | Taglietti Marco | SCYX | Common Stock | D | 0,6900 | 25 000 | 17 | 480 000 | ||||
| 2019-01-04 | 2019-01-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-04 | 2019-01-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 0,54 | 22 500 | 22 500 | |||||
| 2019-01-02 | 2018-12-31 | 4 | Angulo Gonzalez David | SCYX | Common stock | D | 0,4959 | 12 000 | 6 | 121 790 | ||||
| 2019-01-02 | 2018-12-31 | 4 | Taglietti Marco | SCYX | Common stock | D | 0,4600 | 25 000 | 12 | 455 000 | ||||
| 2018-10-03 | 2018-10-01 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1,22 | 0,7900 | 21 595 | 17 | 21 595 | |||
| 2018-09-10 | 2018-09-06 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,2700 | 7 000 | 9 | 108 790 | ||||
| 2018-08-27 | 2018-08-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,2900 | 25 000 | 32 | 429 000 | ||||
| 2018-07-03 | 2018-07-02 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1,69 | 1,1000 | 15 589 | 17 | 15 589 | |||
| 2018-07-03 | 2018-07-02 | 4 | McCourt Marion | SCYX | Stock option (right to buy) | D | 1,69 | 1,1000 | 9 217 | 10 | 9 217 | |||
| 2018-04-04 | 2018-04-02 | 4 | Macdonald Guy | SCYX | Stock option (right to buy) | D | 1,32 | 0,8600 | 19 959 | 17 | 19 959 | |||
| 2018-04-04 | 2018-04-02 | 4 | McCourt Marion | SCYX | Stock option (right to buy) | D | 1,32 | 0,8600 | 11 800 | 10 | 11 800 | |||
| 2018-04-02 | 2018-03-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,3600 | 6 000 | 8 | 101 790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,3900 | 7 000 | 10 | 95 790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 45 000 | 45 000 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 75 000 | 75 000 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6900 | 100 000 | 169 | 404 000 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 1 331 | 1 331 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 2 219 | 2 219 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Sukenick Scott | SCYX | Common Stock | D | 1,6900 | 2 959 | 5 | 2 959 | ||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 5 325 | 5 325 | |||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 8 875 | 8 875 | |||||
| 2018-03-12 | 2018-03-08 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 1,6900 | 11 834 | 20 | 31 834 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 6 655 | 6 655 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 11 092 | 11 092 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,6900 | 14 790 | 25 | 88 790 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 2,00 | 2 662 | 2 662 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 1,85 | 4 437 | 4 437 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Francois Eric | SCYX | Common Stock | D | 1,6900 | 5 917 | 10 | 24 917 | ||||
| 2018-02-13 | 2018-02-09 | 4 | Sukenick Scott | SCYX | Stock option (right to buy) | D | 1,69 | 15 000 | 15 000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Taglietti Marco | SCYX | Stock option (right to buy) | D | 1,69 | 375 000 | 375 000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Francois Eric | SCYX | Stock option (right to buy) | D | 1,69 | 150 000 | 150 000 | |||||
| 2018-02-13 | 2018-02-09 | 4 | Angulo Gonzalez David | SCYX | Stock option (right to buy) | D | 1,69 | 200 000 | 200 000 | |||||
| 2018-01-04 | 2018-01-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,28 | 1,4800 | 11 555 | 17 | 11 555 | |||
| 2018-01-04 | 2018-01-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,28 | 19 989 | 19 989 | |||||
| 2018-01-04 | 2018-01-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,28 | 1,4800 | 6 831 | 10 | 6 831 | |||
| 2017-11-17 | 2017-11-15 | 4 | Sukenick Scott | SCYX | Stock Option (right to buy) | D | 1,75 | 160 000 | 160 000 | |||||
| 2017-10-04 | 2017-10-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,46 | 1 807 | 1 807 | |||||
| 2017-10-04 | 2017-10-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,46 | 10 709 | 10 709 | |||||
| 2017-10-04 | 2017-10-02 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,46 | 6 332 | 6 332 | |||||
| 2017-09-25 | 2017-09-22 | 4 | Taglietti Marco | SCYX | Common Stock | D | 2,2300 | 10 000 | 22 | 303 000 | ||||
| 2017-08-24 | 2017-08-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,8500 | 4 993 | 9 | 292 000 | ||||
| 2017-08-24 | 2017-08-22 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6100 | 7 | 0 | 287 007 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6100 | 10 000 | 16 | 287 000 | ||||
| 2017-08-14 | 2017-08-11 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,5500 | 10 000 | 16 | 72 000 | ||||
| 2017-07-05 | 2017-07-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 1,83 | 2 430 | 2 430 | |||||
| 2017-07-05 | 2017-07-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 1,83 | 14 396 | 14 396 | |||||
| 2017-07-05 | 2017-07-03 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 1,83 | 8 511 | 8 511 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HASTINGS DAVID C | SCYX | Common Stock | D | 1,7500 | 20 000 | 35 | 20 000 | ||||
| 2017-05-15 | 2017-05-12 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 1,7000 | 15 000 | 26 | 62 000 | ||||
| 2017-05-15 | 2017-05-12 | 4 | Taglietti Marco | SCYX | Common Stock | D | 1,6900 | 25 000 | 42 | 277 000 | ||||
| 2017-04-04 | 2017-04-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,65 | 9 941 | 9 941 | |||||
| 2017-04-04 | 2017-04-03 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 2,65 | 5 878 | 5 878 | |||||
| 2017-04-04 | 2017-04-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,65 | 1 678 | 1 678 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 3,02 | 360 000 | 360 000 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 3,02 | 140 000 | 140 000 | |||||
| 2017-02-02 | 2017-01-31 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 3,02 | 100 000 | 100 000 | |||||
| 2017-01-27 | 2017-01-25 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 3,15 | 34 144 | 34 144 | |||||
| 2017-01-27 | 2017-01-25 | 4 | McCourt Marion | SCYX | Stock Option (right to buy) | D | 3,15 | 4 274 | 4 274 | |||||
| 2017-01-05 | 2017-01-03 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3,40 | 7 749 | 7 749 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2017-01-05 | 2017-01-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3,40 | 1 308 | 1 308 | |||||
| 2017-01-05 | 2017-01-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3,40 | 14 499 | 14 499 | |||||
| 2016-12-22 | 2016-12-21 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,3000 | 25 000 | 82 | 251 000 | ||||
| 2016-12-19 | 2016-12-16 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 3,2500 | 4 000 | 13 | 46 000 | ||||
| 2016-10-04 | 2016-10-03 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 4,55 | 6 255 | 6 255 | |||||
| 2016-10-04 | 2016-10-03 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 4,55 | 977 | 977 | |||||
| 2016-09-16 | 2016-09-15 | 4 | Machado Patrick | SCYX | Common Stock | D | 2,9400 | 40 000 | 118 | 60 000 | ||||
| 2016-07-11 | 2016-07-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 2,19 | 12 996 | 12 996 | |||||
| 2016-07-11 | 2016-07-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 2,19 | 2 030 | 2 030 | |||||
| 2016-07-01 | 2016-06-30 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 2,2300 | 32 150 | 72 | 41 000 | ||||
| 2016-07-01 | 2016-06-29 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 2,1800 | 4 800 | 10 | 8 850 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Macdonald Guy | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 18 000 | 0 | 18 000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Macdonald Guy | SCYX | Common Stock | D | 2,3900 | 40 000 | 96 | 40 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Machado Patrick | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 9 000 | 0 | 9 000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Machado Patrick | SCYX | Common Stock | D | 2,3900 | 20 000 | 48 | 20 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Taglietti Marco | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 45 000 | 1 | 45 000 | |||
| 2016-06-28 | 2016-06-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 2,3900 | 100 000 | 239 | 225 000 | ||||
| 2016-06-28 | 2016-06-24 | 4 | Francois Eric | SCYX | Common Stock Warrant (right to buy) | D | 3,00 | 0,0200 | 6 750 | 0 | 6 750 | |||
| 2016-06-28 | 2016-06-24 | 4 | Francois Eric | SCYX | Common Stock | D | 2,3900 | 15 000 | 36 | 15 000 | ||||
| 2016-06-06 | 2016-06-02 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-06-06 | 2016-06-02 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 3,98 | 3,9800 | 8 800 | 35 | 8 800 | |||
| 2016-05-27 | 2016-05-25 | 4 | HANHAM ANN | SCYX | Common Stock | D | 3,6400 | 4 225 | 15 | 4 225 | ||||
| 2016-05-27 | 2016-05-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,2600 | 5 754 | 19 | 124 754 | ||||
| 2016-05-27 | 2016-05-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,2000 | 246 | 1 | 125 000 | ||||
| 2016-05-25 | 2016-05-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,3700 | 5 500 | 19 | 119 000 | ||||
| 2016-05-24 | 2016-05-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,1500 | 3 000 | 9 | 113 500 | ||||
| 2016-05-24 | 2016-05-20 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,1400 | 4 500 | 14 | 110 500 | ||||
| 2016-05-20 | 2016-05-19 | 4 | Taglietti Marco | SCYX | Common Stock | D | 3,0700 | 6 000 | 18 | 106 000 | ||||
| 2016-04-05 | 3/A | Angulo Gonzalez David | SCYX | Common Stock | D | 50 | ||||||||
| 2016-04-05 | 2016-04-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 4,05 | 7 027 | 7 027 | |||||
| 2016-04-05 | 2016-04-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 4,05 | 1 098 | 1 098 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 4,05 | 185 000 | 185 000 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 4,05 | 70 000 | 70 000 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 4,05 | 20 000 | 20 000 | |||||
| 2016-01-06 | 2016-01-04 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 6,10 | 4 666 | 4 666 | |||||
| 2016-01-06 | 2016-01-04 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 6,10 | 729 | 729 | |||||
| 2015-11-24 | 2015-11-24 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,8000 | 7 733 | 53 | 100 000 | ||||
| 2015-11-24 | 2015-11-23 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,7900 | 15 000 | 102 | 92 267 | ||||
| 2015-11-03 | 2015-11-02 | 4 | Francois Eric | SCYX | Stock Option (right to buy) | D | 6,53 | 100 000 | 100 000 | |||||
| 2015-10-05 | 2015-10-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 6,64 | 670 | 670 | |||||
| 2015-10-05 | 2015-10-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 6,64 | 1 607 | 1 607 | |||||
| 2015-10-05 | 2015-10-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 6,64 | 4 286 | 4 286 | |||||
| 2015-09-28 | 2015-09-24 | 4 | Machado Patrick | SCYX | Stock Option (right to buy) | D | 6,89 | 11 700 | 11 700 | |||||
| 2015-09-28 | 2015-09-24 | 4 | HASTINGS DAVID C | SCYX | Stock Option (right to buy) | D | 6,89 | 11 700 | 11 700 | |||||
| 2015-09-18 | 2015-09-15 | 4 | Angulo Gonzalez David | SCYX | Common Stock | D | 7,0000 | 3 000 | 21 | 3 000 | ||||
| 2015-09-02 | 2015-08-31 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,8200 | 25 000 | 196 | 77 267 | ||||
| 2015-08-31 | 2015-08-28 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,1500 | 400 | 3 | 52 267 | ||||
| 2015-08-31 | 2015-08-27 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,0700 | 1 867 | 13 | 51 867 | ||||
| 2015-08-27 | 2015-08-26 | 4 | Taglietti Marco | SCYX | Common Stock | D | 6,9800 | 25 000 | 174 | 50 000 | ||||
| 2015-08-27 | 2015-08-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,1500 | 20 000 | 143 | 25 000 | ||||
| 2015-08-27 | 2015-08-25 | 4 | Taglietti Marco | SCYX | Common Stock | D | 7,1600 | 5 000 | 36 | 5 000 | ||||
| 2015-07-31 | 3 | Woodall Jonathan Sears | SCYX | Common Stock | D | 1 000 | ||||||||
| 2015-07-31 | 3 | Woodall Jonathan Sears | SCYX | Common Stock | D | 1 000 | ||||||||
| 2015-07-24 | 2015-07-22 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 8,64 | 8 800 | 8 800 | |||||
| 2015-07-06 | 2015-07-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8,86 | 502 | 502 | |||||
| 2015-07-06 | 2015-07-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8,86 | 2 974 | 2 974 | |||||
| 2015-07-06 | 2015-07-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,86 | 1 465 | 1 465 | |||||
| 2015-06-05 | 2015-06-04 | 4 | PENHOET EDWARD | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8,65 | 8 800 | 8 800 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Angulo Gonzalez David | SCYX | Stock Option (right to buy) | D | 8,65 | 125 000 | 125 000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,76 | 1 976 | 1 976 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 8,76 | 1 976 | 1 976 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,76 | 1 207 | 1 207 | |||||
| 2015-04-03 | 2015-04-01 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 8,76 | 554 | 544 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 8,76 | 330 000 | 330 000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,76 | 1 690 | 1 690 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 8,76 | 50 000 | 50 000 | |||||
| 2015-04-03 | 2015-04-01 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 8,76 | 9 541 | 9 541 | |||||
| 2015-02-27 | 2015-02-25 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 10,00 | 486 | 486 | |||||
| 2015-02-27 | 2015-02-25 | 4 | GILMAN STEVEN C | SCYX | Stock Option (right to buy) | D | 10,00 | 7 830 | 7 830 | |||||
| 2015-01-06 | 2015-01-02 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 9,96 | 2 047 | 2 047 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 9,96 | 869 | 869 | |||||
| 2015-01-06 | 2015-01-02 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 9,96 | 1 738 | 1 738 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 9,96 | 1 660 | 1 660 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 9,96 | 1 738 | 1 738 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 9,96 | 1 274 | 1 274 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 10,81 | 1 530 | 1 530 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Taglietti Marco | SCYX | Stock Option (right to buy) | D | 10,81 | 7 830 | 7 830 | |||||
| 2014-12-04 | 2014-12-02 | 4 | Macdonald Guy | SCYX | Stock Option (right to buy) | D | 10,81 | 7 830 | 7 830 | |||||
| 2014-10-02 | 2014-10-01 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 7,70 | 2 048 | 2 048 | |||||
| 2014-10-02 | 2014-10-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 7,70 | 1 648 | 1 648 | |||||
| 2014-10-02 | 2014-07-01 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,03 | 1 964 | 1 964 | |||||
| 2014-10-02 | 2014-07-01 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,03 | 1 581 | 1 581 | |||||
| 2014-10-02 | 2014-10-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 7,70 | 2 248 | 2 248 | |||||
| 2014-10-02 | 2014-07-01 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,03 | 2 155 | 2 155 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 9,64 | 25 230 | 25 230 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 24,48 | −9 803 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | PRUETTE EILEEN | SCYX | Stock Option (right to buy) | D | 9,64 | 9 803 | 9 803 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 187 052 | 187 052 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 30,60 | −1 960 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 1 960 | 1 960 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | −2 941 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 25,91 | −2 941 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 2 941 | 2 941 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 2 941 | 2 941 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | −3 676 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 25,50 | −3 676 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 3 676 | 3 676 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 3 676 | 3 676 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | −931 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 931 | 931 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | −7 352 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 20,40 | −7 352 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 7 352 | 7 352 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Ribeill Yves J | SCYX | Stock Option (right to buy) | D | 9,64 | 7 352 | 7 352 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 57 420 | 57 420 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 30,60 | −833 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 833 | 833 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 25,91 | −1 470 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 1 470 | 1 470 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 25,50 | −1 225 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | −1 225 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 1 225 | 1 225 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 1 225 | 1 225 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | −808 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 808 | 808 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | −490 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 490 | 490 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | −934 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 934 | 934 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 20,40 | −960 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Osborne, Jr. Charles F | SCYX | Stock Option (right to buy) | D | 9,64 | 960 | 960 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 9,64 | 26 970 | 26 970 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 10,00 | −46 636 | 0 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Sable Carole | SCYX | Stock Option (right to buy) | D | 9,64 | 46 636 | 46 636 | |||||
| 2014-06-13 | 2014-06-11 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,73 | 1 321 | 1 321 | |||||
| 2014-06-13 | 2014-06-11 | 4 | KIRBY PAMELA J | SCYX | Stock Option (right to buy) | D | 8,73 | 5 220 | 5 220 | |||||
| 2014-06-13 | 2014-06-11 | 4 | PENHOET EDWARD | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,73 | 1 204 | 1 204 | |||||
| 2014-06-13 | 2014-06-11 | 4 | HANHAM ANN | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Langlois Patrick | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,73 | 969 | 969 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Nothias Jean-Yves | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Chaoui Mounia | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Arthaud Laurent | SCYX | Stock Option (right to buy) | D | 8,73 | 3 480 | 3 480 | |||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Merial Limited | SCYX | Shares | I | 1 805 363 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventisub Inc. | SCYX | Shares | I | 3 177 057 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventisub Inc. | SCYX | Shares | I | 3 177 057 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Merial Limited | SCYX | Shares | I | 1 805 363 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventis Agriculture | SCYX | Shares | I | 1 725 808 | ||||||||
| 2014-05-09 | 3 | Sanofi Via wholly owned subsidiary Aventis Agriculture | SCYX | Shares | I | 1 725 808 | ||||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series D-2 Preferred Stock | D | −341 456 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series D-1 Preferred Stock | D | −955 215 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series C Preferred Stock | D | −342 726 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Series B Preferred Stock | D | −188 679 | 0 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −3 501 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −5 251 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −5 251 | 0 | |||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 10,0000 | 10 000 | 100 | 237 598 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 16 738 | 227 598 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 46 824 | 210 860 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 96 921 | 164 036 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 53 112 | 67 115 | ||||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0,2000 | 3 501 | 1 | 14 003 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-09 | 2014-05-07 | 4 | F.C.P.R. Genavent | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 3/A | Arthaud Laurent By wife | SCYX | Common Stock | I | 3 738 | ||||||||
| 2014-05-08 | 3/A | Arthaud Laurent | SCYX | Common Stock | D | 735 | ||||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Series D-2 Preferred Stock | D | −260 000 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −12 745 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock | D | 12 745 | 25 590 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | KIRBY PAMELA J | SCYX | Common Stock | D | 0,2000 | 12 745 | 3 | 12 745 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series D-2 Preferred Stock | I | −53 915 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series D-1 Preferred Stock | I | −37 702 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Series C Preferred Stock | I | −20 975 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −3 033 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −174 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −174 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series D-2 Preferred Stock | D | −1 417 315 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series D-1 Preferred Stock | D | −1 024 876 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Series C Preferred Stock | D | −570 159 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −82 454 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −4 551 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −4 551 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 10,0000 | 31 934 | 319 | 45 736 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 2 642 | 13 802 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 1 848 | 11 160 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 5 931 | 9 312 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0,2000 | 3 033 | 1 | 3 381 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0,2000 | 174 | 0 | 348 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP By Alta Embarcadero BioPharma Partners II, LLC | SCYX | Common Stock | I | 0,2000 | 174 | 0 | 348 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 10,0000 | 868 066 | 8 681 | 1 240 575 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 69 476 | 372 509 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 50 239 | 303 033 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 161 238 | 252 794 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0,2000 | 82 454 | 16 | 91 556 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0,2000 | 4 551 | 1 | 9 102 | ||||
| 2014-05-08 | 2014-05-07 | 4 | ALTA BIOPHARMA PARTNERS II LP | SCYX | Common Stock | D | 0,2000 | 4 551 | 1 | 9 102 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Series D-2 Preferred Stock | I | −107 142 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock | I | 5 252 | 10 503 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Langlois Patrick By DFC Langlois | SCYX | Common Stock | I | 0,2000 | 5 251 | 1 | 26 785 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series D-2 Preferred Stock | I | −623 880 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series D-1 Preferred Stock | I | −863 672 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series C Preferred Stock | I | −313 996 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Series B Preferred Stock | I | −166 482 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −25 998 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 10,0000 | 50 000 | 500 | 295 077 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 30 582 | 245 077 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 42 336 | 214 495 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 88 796 | 172 159 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 46 863 | 83 363 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0,2000 | 25 998 | 5 | 36 500 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Nothias Jean-Yves By FCPR Biotechnology Fund | SCYX | Common Stock | I | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series D-2 Preferred Stock | D | −623 880 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series D-1 Preferred Stock | D | −863 672 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series C Preferred Stock | D | −313 996 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Series B Preferred Stock | D | −166 482 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −25 998 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −5 251 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 10,0000 | 50 000 | 500 | 295 077 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 30 582 | 245 077 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 42 336 | 214 495 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 88 796 | 172 159 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 46 863 | 83 363 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0,2000 | 25 998 | 5 | 36 500 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | FCPR Biotechnology Fund | SCYX | Common Stock | D | 0,2000 | 5 251 | 1 | 10 502 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Series D-2 Preferred Stock | D | −12 142 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −595 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock | D | 595 | 1 190 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ribeill Yves J | SCYX | Common Stock | D | 0,2000 | 595 | 0 | 595 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Series D-2 Preferred Stock | I | −1 665 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Series D-1 Preferred Stock | I | −8 127 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −222 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −34 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock Warrant (right to buy) | I | 0,20 | −34 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 81 | 4 507 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 398 | 4 426 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0,2000 | 222 | 0 | 4 028 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0,2000 | 34 | 0 | 3 806 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Arthaud Laurent By wife | SCYX | Common Stock | I | 0,2000 | 34 | 0 | 3 806 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series D-2 Preferred Stock | D | −3 010 807 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series D-1 Preferred Stock | D | −809 584 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series C Preferred Stock | D | −340 509 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Series B Preferred Stock | D | −109 879 | 0 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −43 704 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −14 005 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock Warrant (right to buy) | D | 0,20 | −14 005 | 0 | |||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 10,0000 | 28 000 | 280 | 414 211 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 147 588 | 386 211 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 39 685 | 238 623 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 96 294 | 198 938 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 30 930 | 102 644 | ||||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0,2000 | 43 704 | 9 | 71 714 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0,2000 | 14 005 | 3 | 28 010 | ||||
| 2014-05-08 | 2014-05-07 | 4 | Ventech Capital II | SCYX | Common Stock | D | 0,2000 | 14 005 | 3 | 28 010 | ||||
| 2014-05-02 | 3 | Garrett Michael C | SCYX | Common Stock | D | 6 216 | ||||||||
| 2014-05-02 | 3 | Garrett Michael C | SCYX | Common Stock | D | 6 216 | ||||||||
| 2014-05-02 | 3 | Ribeill Yves J | SCYX | Common Stock | D | 33 950 | ||||||||
| 2014-05-02 | 3 | Ribeill Yves J | SCYX | Common Stock | D | 33 950 | ||||||||
| 2014-05-02 | 3 | Arthaud Laurent | SCYX | Common Stock | D | 1 470 | ||||||||
| 2014-05-02 | 3 | Arthaud Laurent | SCYX | Common Stock | D | 1 470 | ||||||||
| 2014-05-02 | 3 | Osborne, Jr. Charles F | SCYX | Common Stock | D | 17 900 | ||||||||
| 2014-05-02 | 3 | Osborne, Jr. Charles F | SCYX | Common Stock | D | 17 900 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
